+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Release of Matrix Metalloproteinases-2 and 9 by S-Nitrosylated Caveolin-1 Contributes to Degradation of Extracellular Matrix in tPA-Treated Hypoxic Endothelial Cells



Release of Matrix Metalloproteinases-2 and 9 by S-Nitrosylated Caveolin-1 Contributes to Degradation of Extracellular Matrix in tPA-Treated Hypoxic Endothelial Cells



Plos One 11(2): E0149269



Intracranial hemorrhage remains the most feared complication in tissue plasminogen activator (tPA) thrombolysis for ischemic stroke. However, the underlying molecular mechanisms are still poorly elucidated. In this study, we reported an important role of caveolin-1 (Cav-1) s-nitrosylation in matrix metalloproteinase (MMP)-2 and 9 secretion from tPA-treated ischemic endothelial cells. Brain vascular endothelial cells (bEND3) were exposed to oxygen-glucose deprivation (OGD) for 2 h before adding recombinant human tPA for 6 h. This treatment induced a significant increase of MMP2 and 9 in the media of bEND3 cells and a simultaneous degradation of fibronectin and laminin β-1, the two main components of extracellular matrix (ECM). Inhibition of MMP2 and 9 with SB-3CT completely blocked the degradation of fibronectin and laminin β-1. ODG+tPA treatment led to Cav-1 shedding from bEND3 cells into the media. Notably, OGD triggered nitric oxide (NO) production and S-nitrosylationof Cav-1 (SNCav-1). Meanwhile tPA induced activation of ERK signal pathway and stimulates the secretion of SNCav-1. Pretreatment of bEND3 cells with C-PTIO (a NO scavenger) or U0126 (a specific ERK inhibitor) significantly reduced OGD-induced S-nitrosylation of Cav-1 in cells and blocked the secretion of Cav-1 and MMP2 and 9 into the media as well as the degradation of fibronectin and laminin β-1 in OGD and tPA-treated cells. These data indicate that OGD-triggered Cav-1 S-nitrosylation interacts with tPA-induced ERK activation to augment MMP2 and 9 secretion and subsequent ECM degradation, which may account for the exacerbation of ischemic blood brain barrier damage following tPA thrombolysis for ischemic stroke.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 058733596

Download citation: RISBibTeXText

PMID: 26881424

DOI: 10.1371/journal.pone.0149269


Related references

Matrix metalloproteinases produced by IL-2 activated natural killer cells and extracellular matrix degradation. Natural Immunity 15(4): 187, 1996-, 1997

Vectorial secretion of extracellular matrix proteins, matrix-degrading proteinases, and tissue inhibitor of metalloproteinases by endothelial cells. Journal of Biological Chemistry 265(1): 445-451, 1990

1,25-Dihydroxy vitamin D3 is an autocrine regulator of extracellular matrix turnover and growth factor release via ERp60-activated matrix vesicle matrix metalloproteinases. Cells, Tissues, Organs 189(1-4): 70-74, 2008

Extracellular matrix metalloproteinase inducer (EMMPRIN) remodels the extracellular matrix through enhancing matrix metalloproteinases (MMPs) and inhibiting tissue inhibitors of MMPs expression in HPV-positive cervical cancer cells. European Journal of Gynaecological Oncology 36(5): 539-545, 2015

A role for extracellular matrix degradation and matrix metalloproteinases in senile dementia?. Acta Neuropathologica. 87(3): 308-312, 1994

Degradation of extracellular matrix by matrix metalloproteinases and joint destruction. Seikagaku. Journal of Japanese Biochemical Society 73(11): 1309-1321, 2002

Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs. Journal of Enzyme Inhibition and Medicinal Chemistry 31(Sup1): 177-183, 2016

VAMP3, syntaxin-13 and SNAP23 are involved in secretion of matrix metalloproteinases, degradation of the extracellular matrix and cell invasion. Journal of Cell Science 122(Pt 22): 4089-4098, 2010

Cyclic mechanical stress induces extracellular matrix degradation in cultured chondrocytes via gene expression of matrix metalloproteinases and interleukin-1. Journal of Biochemistry 125(5): 966-975, 1999

Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases. Cancer Research 65(8): 3193-3199, 2005

1alpha,25(OH)2D3 is an autocrine regulator of extracellular matrix turnover and growth factor release via ERp60 activated matrix vesicle metalloproteinases. Journal of Steroid Biochemistry and Molecular Biology 103(3-5): 467-472, 2007

In pneumococcal meningitis a water soluble inhibitor of matrix metalloproteinases and TNF-alpha converting enzyme attenuates seizures, extracellular matrix degradation and brain injury. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 40: 50, 2000

Alpha,25OH2D-3 is an autocrine regulator of extracellular matrix turnover and growth factor release via ERp60 activated matrix vesicle metalloproteinases. Journal of Steroid Biochemistry and Molecular Biology 103(3-5, Sp. Iss. SI): 467-472, 2000

The extracellular matrix is a novel attribute of endothelial progenitors and of hypoxic mature endothelial cells. Faseb Journal 26(12): 4925-4936, 2013